Evotec SE (ETR:EVT – Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of €7.59 ($8.16) and traded as low as €7.10 ($7.63). Evotec shares last traded at €7.12 ($7.65), with a volume of 2,952,098 shares traded.
Evotec Stock Up 0.1 %
The stock has a 50 day simple moving average of €8.35 and a 200 day simple moving average of €7.59. The company has a market capitalization of $1.32 billion, a price-to-earnings ratio of -7.70, a P/E/G ratio of 0.98 and a beta of 1.05.
Evotec Company Profile
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
See Also
- Five stocks we like better than Evotec
- Following Congress Stock Trades
- Corporate Crawl: Where Business Trips Turn Into Party Nights?
- What is Insider Trading? What You Can Learn from Insider Trading
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Stock Splits, Do They Really Impact Investors?
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
